Gene: RNF26
Official Full Name: ring finger protein 26provided by HGNC
Gene Summary: The protein encoded by this intronless gene contains a C3HC5 type of RING finger, a motif known to be involved in protein-DNA and protein-protein interactions. The expression of this gene was found to be upregulated in cancer cell lines derived from different types of cancer. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06641 | RNF26 Knockout cell line (HeLa) | Human | RNF26 | 1:3~1:6 | Negative | Online Inquiry |
KO06642 | RNF26 Knockout cell line (HCT 116) | Human | RNF26 | 1:2~1:4 | Negative | Online Inquiry |
KO06643 | RNF26 Knockout cell line (HEK293) | Human | RNF26 | 1:3~1:6 | Negative | Online Inquiry |
KO06644 | RNF26 Knockout cell line (A549) | Human | RNF26 | 1:3~1:4 | Negative | Online Inquiry |
RNF26 Gene Knockout Cell Lines are specialized cellular models developed through precise gene editing techniques to disrupt the RNF26 gene, which encodes an E3 ubiquitin ligase involved in regulating various cellular pathways, including those related to protein degradation and signal transduction. These cell lines enable researchers to explore the biological significance of the RNF26 gene, particularly in the context of cellular stress responses, oncogenesis, and developmental biology.
The primary function of RNF26 knockout models is to facilitate investigations into the downstream effects of RNF26 loss, shedding light on its mechanistic roles in cellular homeostasis. By inhibiting the ubiquitin-proteasome system, researchers can elucidate critical pathways affected in conditions like cancer and neurodegeneration. This model not only aids in gene function studies but also supports investigations into therapeutic interventions targeting pathways influenced by RNF26.
Scientifically, the significance of RNF26 knockout cell lines is profound. They offer valuable platforms for drug discovery and biomarker identification, particularly for conditions where RNF26 is implicated. Their application in basic and applied research is crucial, providing insights into E3 ligase regulation and its relevance in disease processes.
Compared to conventional cell lines, our RNF26 knockout models provide higher specificity and reliability in experimental outcomes, allowing for more precise functional studies. They also eliminate background interference from the RNF26 protein, leading to clearer interpretations of cellular behaviors in response to various stimuli.
These knockout cell lines represent an invaluable resource for researchers and clinicians aiming to advance their understanding of RNF26-related pathways. The ability to manipulate this gene opens new avenues for innovative research, enhancing the potential for developing targeted therapies.
Our company is committed to excellence in biotechnological innovations, backed by a team of experts dedicated to providing high-quality biological products that empower the scientific community and accelerate research breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.